Last updated: 1 April 2024 at 9:33pm EST

Dr. Michael Zinda Ph.D. Net Worth




The estimated Net Worth of Michael Zinda is at least $3.66 Million dollars as of 28 March 2024. Dr Zinda owns over 860 units of Repare Therapeutics stock worth over $202,061 and over the last 4 years he sold RPTX stock worth over $2,867,945. In addition, he makes $585,846 as Exec. VP & Chief Scientific Officer at Repare Therapeutics.

Dr D RPTX stock SEC Form 4 insiders trading

Dr has made over 13 trades of the Repare Therapeutics stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 860 units of RPTX stock worth $3,999 on 28 March 2024.

The largest trade he's ever made was exercising 57,979 units of Repare Therapeutics stock on 22 December 2020 worth over $115,378. On average, Dr trades about 14,403 units every 67 days since 2020. As of 28 March 2024 he still owns at least 71,908 units of Repare Therapeutics stock.

You can see the complete history of Dr Zinda stock trades at the bottom of the page.





Dr. Michael Zinda Ph.D. biography

Dr. Michael Zinda Ph.D. is the Exec. VP & Chief Scientific Officer at Repare Therapeutics.

What is the salary of Dr D?

As the Exec. VP & Chief Scientific Officer of Repare Therapeutics, the total compensation of Dr D at Repare Therapeutics is $585,846. There are 2 executives at Repare Therapeutics getting paid more, with Lloyd Mitchell Segal having the highest compensation of $878,368.



How old is Dr D?

Dr D is 50, he's been the Exec. VP & Chief Scientific Officer of Repare Therapeutics since . There are 2 older and 1 younger executives at Repare Therapeutics. The oldest executive at Repare Therapeutics Inc. is Dr. Maria Koehler M.D., Ph.D., 64, who is the Exec. VP & Chief Medical Officer.

What's Dr D's mailing address?

Michael's mailing address filed with the SEC is C/O REPARE THERAPEUTICS INC., , ST-LAURENT, A8, H4S 1Z9.

Insiders trading at Repare Therapeutics

Over the last 4 years, insiders at Repare Therapeutics have traded over $111,956,457 worth of Repare Therapeutics stock and bought 8,747,790 units worth $117,182,784 . The most active insiders traders include Partners L P/Ilbiotechnolog..., David P Bonita, and Group, Llc Green Jeremy Red.... On average, Repare Therapeutics executives and independent directors trade stock every 15 days with the average trade being worth of $446,135. The most recent stock trade was executed by Lloyd Mitchell Segal on 28 March 2024, trading 5,141 units of RPTX stock currently worth $23,751.



What does Repare Therapeutics do?

Repare Therapeutics Inc., a precision oncology company, discovers and develops novel therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an oral small-molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing RP-6306, a proprietary drug discovery program for tumors with genetic alterations characterized by CCNE1 amplification; and Polymerase Theta program, a SL target associated with BRCA mutations and other genomic alterations. Repare Therapeutics Inc. was incorporated in 2016 and is headquartered in Montréal, Canada.



What does Repare Therapeutics's logo look like?

Repare Therapeutics Inc. logo

Complete history of Dr Zinda stock trades at Repare Therapeutics

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
28 Mar 2024 Michael Zinda
EVP and CHIEF SCIENTIFIC OFFICER
Sale 860 $4.65 $3,999
28 Mar 2024
71,908
25 Mar 2024 Michael Zinda
EVP and CHIEF SCIENTIFIC OFFICER
Sale 1,350 $4.67 $6,305
25 Mar 2024
72,768
7 Jun 2023 Michael Zinda
EVP and CHIEF SCIENTIFIC OFFICER
Sale 9,273 $12.03 $111,554
7 Jun 2023
60,118
6 Jun 2023 Michael Zinda
EVP and CHIEF SCIENTIFIC OFFICER
Sale 1,200 $12.04 $14,448
6 Jun 2023
69,391
15 Mar 2022 Michael Zinda
EVP and CHIEF SCIENTIFIC OFFICER
Sale 533 $11.30 $6,023
15 Mar 2022
46,041
23 Nov 2021 Michael Zinda
EVP and CHIEF SCIENTIFIC OFFICER
Option 46,041 $2.00 $92,082
23 Nov 2021
46,574
15 Nov 2021 Michael Zinda
EVP and CHIEF SCIENTIFIC OFFICER
Sale 20,000 $27.33 $546,600
15 Nov 2021
533
16 Aug 2021 Michael Zinda
EVP and CHIEF SCIENTIFIC OFFICER
Sale 15,000 $33.99 $509,850
16 Aug 2021
20,533
17 May 2021 Michael Zinda
EVP and CHIEF SCIENTIFIC OFFICER
Sale 15,000 $32.71 $490,650
17 May 2021
35,533
28 Dec 2020 Michael Zinda
EVP and CHIEF SCIENTIFIC OFFICER
Sale 34,744 $33.92 $1,178,516
28 Dec 2020
50,533
22 Dec 2020 Michael Zinda
EVP and CHIEF SCIENTIFIC OFFICER
Option 57,979 $1.99 $115,378
22 Dec 2020
85,661
21 Dec 2020 Michael Zinda
EVP and CHIEF SCIENTIFIC OFFICER
Option 40,000 $2.43 $97,200
21 Dec 2020
125,229
16 Dec 2020 Michael Zinda
EVP and CHIEF SCIENTIFIC OFFICER
Option 17,277 $1.84 $31,790
16 Dec 2020
93,550


Repare Therapeutics executives and stock owners

Repare Therapeutics executives and other stock owners filed with the SEC include: